In contrast, in BC patients, DRD2 antagonists may demonstrate the opposite effect, including the reduction in tumor growth and invasion and the induction of cell cycle arrest and apoptosis [17,19,22,28,29,30,31,32,33]. Here, DRD2 is linked to breast cancer.